Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.

Volume 3 (2006), Issue 5 (May)

1. Effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol-induced chemical kindling in mice.
   Fundam Clin Pharmacol, 20(3): 255-61. [Abstract] [Full-text]
2. Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx and Arcoxia.
   Bioorg Med Chem Lett, 16(12): 3209-12. [Abstract] [Full-text]
3. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.
   Clin Pharmacol Ther, 79(5): 407-18. [Abstract] [Full-text]
4. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
   Arthritis Rheum, 54(5): 1378-89. [Abstract] [Full-text]
5. Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.
   Clin Cancer Res, 12(10): 3092-8. [Abstract] [Full-text]
6. Analgesic action of acetaminophen in symptomatic osteoarthritis of the knee.
   Rheumatology (Oxford), 45(6): 765-70. [Abstract] [Full-text]
7. Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor.
   Melanoma Res, 16(3): 263-265. [Abstract] [Full-text]
8. Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors.
   CMAJ, 174(11): 1563-9. [Abstract] [Full-text]
9. Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain.
   Neuropharmacology, 50(7): 814-23. [Abstract] [Full-text]

© 2004-2008 Vioxx Research Today. All Rights Reserved.